title: Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis.
authors: M E
authors: ME
authors: Hettema
authors: D
authors: D
authors: Zhang
authors: H
authors: H
authors: Bootsma
authors: C G M
authors: CG
authors: Kallenberg
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000150:complications*; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan